Clinical Trials List
Protocol Number3160A4-3000-WW
Not yet recruiting
2008-07-01 - 2017-12-31
Phase III
Terminated2
-
Trial Applicant
Wyeth-Ayerst (Asia) LLC
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 林炫聿 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
412 participants
